Cody Desjardins

Cody Desjardins, Ph.D., is Senior Director at Dyne Therapeutics, where he has helped pioneer targeted delivery approaches for neuromuscular diseases. With prior experience at Sarepta Therapeutics, he played a key role in launching Dyne and advancing its platform for exon-skipping therapies in DMD, spanning preclinical development to clinical translation. Dr. Desjardins has dedicated his career to designing novel therapeutics that overcome delivery challenges, with a particular focus on advancing oligonucleotide delivery to the central nervous system.